(Q73526621)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10708930%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Do we need prognostic factors in nodal-negative breast cancer? Arbiter (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10708930%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

D F Hayes

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10708930%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 February 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10708930%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10708930%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10708930%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10708930%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

302-306

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10708930%20AND%20SRC:MED&resulttype=core&format=json

Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer.

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900303-2

7 January 2021

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900303-2

7 January 2021

Statistical aspects of prognostic factor studies in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900303-2

7 January 2021

Breast cancer prognostic factors: evaluation guidelines.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900303-2

7 January 2021

Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900303-2

7 January 2021

Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900303-2

7 January 2021

Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900303-2

7 January 2021

Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900303-2

7 January 2021

Assessing the clinical impact of prognostic factors: when is "statistically significant" clinically useful?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900303-2

7 January 2021

10.1016/S0959-8049(99)00303-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10708930%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference